And given how powerful peptides are, says Dr
Mechanistically, semaglutide was found to enhance autophagy, as indicated by increased expression of autophagy-related proteins such as LC3-II, Atg7, and Beclin-1, and decreased expression of p62
Manee-In S, Parmornsupornvichit S, Kraiprayoon S, Tharasanit T, Chanapiwat P, Kaeoket K
Search strategy We used the following search strategy: (irritable bowel syndrome OR IBS OR spastic colon OR irritable colon) AND (Glucagon like peptide 1 receptor agonist OR GLP-1 agonist OR Semaglutide OR Dulaglutide OR Exenatide OR Liraglutide OR Lixisenatide OR Tirzepatide)
A 2021 randomized controlled trial demonstrated that exenatide, a GLP-1 receptor agonist, significantly slowed cognitive decline in patients with early-stage Parkinsons disease compared to a placebo group (Athauda et al., 2021)
Similarly, the other clinical trial comparing the effects of HCQ with gemcitabine/nab-paclitaxel in a neoadjuvant setting also failed to demonstrate improvements in overall survival and relapse-free survival [101]
